Hngr(310)FC GMP3 campaign and octet method development
Active Awarded Last action
- Contract number
- 75N91019F00140
- Awardee
-
Leidos Biomedical Research Inc. UEI HV8BH9BPG8Y9 Part of Leidos Holdings, Inc.
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $9,222,324
Award facts
- Opportunity
-
- N02CO7240681 Solicitation number
- Contract value 88% obligated
-
- $9,222,323.89 Current, with exercised options
- $10,521,320.89 Potential, with all options
- Completion date 89% complete
-
- Current, with exercised options
- Potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Frederick, MD 21702, USA
- Legislative mandates
-
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | -$9,236 | |
| Other Administrative Action | -$1,654,198 | |
| Other Administrative Action | $0 | |
| Change Order | $1,363 | |
| Change Order | $2,794,696 | |
| Change Order | -$94,461 | |
| Supplemental Agreement for work within scope | $1,645,800 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $4,286,448 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $2,251,912 |
Show all 14
About this award
The National Cancer Institute issued a $10.5 million ceiling delivery order to Leidos Biomedical Research Inc. on September 16, 2019, covering HNGR(310)FC GMP3 campaign and octet method development and neuresta drug substance manufacturing. The order is cost-plus-fixed-fee, no set-aside was used, and performance runs through September 15, 2027 at Frederick, Maryland.
A Malvern Panalytical Inc. sub-award dated July 1, 2026 supplies an Aeris 600 W X-ray diffraction system with installation and two classroom training seats.
Service Contract Inventory reporting shows government-invoiced amounts of $387 thousand in FY2020, $902 thousand in FY2021, $250 thousand in FY2022, $881 thousand in FY2023, $1.4 million in FY2024, and $83 thousand in FY2025. The FY2025 labor footprint is 1.4 FTEs across 2,914 contractor hours, a derived government-paid rate of $28.37 per hour, with one subcontractor and 93% of contractor hours subcontracted. Derived rates run from $1,054.98 per hour in FY2021 to $3,894.82 in FY2023 and $28.37 in FY2025, and the reported trend is declining. Rates are blended in years with subcontractor participation and should be treated as approximate. FY2020 and FY2021 are civilian-only inventories, so comparisons spanning FY2021 to FY2022 are approximate.
Subawards
| Subcontractor | Amount | Awarded |
|---|---|---|
| Malvern Panalytical Inc. | $141,295 |
Quick answers
Who was awarded contract 75N91019F00140?
75N91019F00140 was awarded to Leidos Biomedical Research Inc. by National Cancer Institute (National Institutes of Health) on September 16, 2019.
How much is contract 75N91019F00140 worth?
The government has obligated $9,222,324 on 75N91019F00140. Its potential value, with all options, is $10,521,321.
Is contract 75N91019F00140 an order under another contract?
Yes. 75N91019F00140 is a delivery order under 75N91019D00024, an indefinite delivery contract.
Was contract 75N91019F00140 competed?
The extent of competition for 75N91019F00140 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award